From bringing in a mere 350 scientists in an embattled field 12 years ago, this year's Alliance for Regenerative Medicine Cell and Gene Meeting brought in more than 1,200.
After a decade at the helm, Organovo's Keith Murphy is stepping down, to be replaced by eStudySite's Taylor Crouch. It marks a new era of commercialization for the San Diego company that has long been a pioneer in the 3D bioprinting of tissues and organs.
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
The high costs of clinical trials could eventually make 3-D bioprinting a go-to technology for pharma and biotech, providing better data to spot toxicity early and helping the pharma industry avoid costly mistakes.
BioBots, a Philadelphia startup that develops 3D bioprinters, will debut its new $10,000, desktop machine that will help scientists print out their own tissues for preclinical research.
3-D printing is one of the fastest growing industries in 2013 and one of the hottest trends in healthcare. Though it’s been in development for years, the recent innovations and subsequent media attention might have left you blindsided. Be sure to catch up on bioprinting, one way the tech’s being used in healthcare, with this […]
The cost of bringing a therapeutic to market varies but was recently calculated to be an average of $5 billion. Organovo’s 3-D printing platform for organs and organ tissue could make the cost of bringing therapeutics to market more cost-effective. How? It’s developing effective models for testing the efficacy and toxicology of medications in humans. […]
We can now grow complex human brain tissue in a test tube. Scientists in Vienna, Austria, used a method that allows pluripotent stem cells to develop into mini-brains (i.e., cerebral organoids) that even have several distinct brain regions, according to an article in this issue of Nature. While this year has seen 3-D printed miniature […]
The Methuselah Foundation, a charity devoted to innovation in regenerative medicine, will divvy up at least $500,000 in the form of grants between selected public and private research universities and private non-profit research institutes, Organovo Holdings, Inc., a San Diego-based biotech company, announced today. The catch? Eligibility is limited to those research institutions using Organovo’s NovoGen […]
3D printing gets a lot of hype for the things it will someday be able to do, like replicate human organs and create customized prosthetics. But it’s doing some pretty cool things in the meantime, too, like helping researchers create living models of tumors so they can more effectively identify and test potential drugs. Bioprinting […]
Three-dimensional printing marks an exciting frontier in healthcare in which companies can use advanced 3D printers to make everything from human ear and foot models for research to prosthetics that can transform a toddler’s life. But 3D bio-printing — producing human tissue and ultimately human organs using inks composed of different human cells — is almost […]
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
